Korean Circ J.  2024 Mar;54(3):158-159. 10.4070/kcj.2024.0561.

Author’s Reply to Clinical Implication of New-Onset Atrial Fibrillation in the Individuals With Cardiac Implantable Electronic Devices

• Lee SR
• Lee JH
• Choi EK

• KMID: 2554145
• DOI: http://doi.org/10.4070/kcj.2024.0561

Reference

1. Kataoka N, Imamura T. Clinical implication of new-onset atrial fibrillation in the individuals with cardiac implantable electronic devices. Korean Circ J. 2024; 54:156–157. PMID: 38506108.

2. Lee SR, Lee JH, Choi EK, et al. Risk of atrial fibrillation and adverse outcomes in patients with cardiac implantable electronic devices. Korean Circ J. 2024; 54:13–27. PMID: 37973974.

3. Liu Y, Zheng Y, Tse G, et al. Association between sick sinus syndrome and atrial fibrillation: a systematic review and meta-analysis. Int J Cardiol. 2023; 381:20–36. PMID: 37023861.

4. Kubala M, de Chillou C, Bohbot Y, Lancellotti P, Enriquez-Sarano M, Tribouilloy C. Arrhythmias in patients with valvular heart disease: gaps in knowledge and the way forward. Front Cardiovasc Med. 2022; 9:792559. PMID: 35242822.

5. Kirchhof P, Camm AJ, Goette A, et al. Early rhythm-control therapy in patients with atrial fibrillation. N Engl J Med. 2020; 383:1305–1316. PMID: 32865375.